Crossmark

Bioactivity of novel isoxazole-fused heterocycles: comprehensive antimicrobial, antioxidant activities, SwissADME predictions, molecular docking, and DFT analysis

Crossref DOI link: https://doi.org/10.1007/s11030-025-11180-z

Published Online: 2025-04-17

Published Print: 2026-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Reheim, Mohamed A. M. Abdel

Abdou, Moaz M.

El-Gaby, Mohamed S. A.

Al-Omari, Mohammad Hasan

Abu-Rayyan, Ahmed

Al-Assy, Waleed H.

Refat, Hala M.

Sarhan, Ahmed A. M.

Hafiz, Ibrahim S. Abdel
Funding

Funding for this research was provided by:

Egyptian Petroleum Research Institute
License Information

Text and Data Mining valid from 2025-04-17

Version of Record valid from 2025-04-17
More Information

Article History

Received: 22 September 2024

Accepted: 28 March 2025

First Online: 17 April 2025

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below